Live from the NIH registry
Studies recruiting near Savannah right now
Top 25 of 168 recruiting studies, sorted by proximity — each links to its official registry page
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler — Savannah, Georgia (6.1 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Phase 3
Interventional 600 participants sought
Summit Cancer Care PC — Savannah, Georgia (6.1 mi)
· Sponsor: Hoffmann-La Roche
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8
Phase 3
Interventional 356 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi)
· Sponsor: NRG Oncology
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Atopic Dermatitis
N/A
Observational 1,000 participants sought
Galderma Investigational Site 7106 — Bluffton, South Carolina (23.7 mi)
· Sponsor: Galderma R&D
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Malignancy
N/A
Observational 240 participants sought
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler — Savannah, Georgia (6.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
Asthma
Phase 3
Interventional 231 participants sought
Research Site — Savannah, Georgia (6.1 mi)
· Sponsor: AstraZeneca
A Study to Assess the Efficacy, Safety and Tolerability of AT673 Co-administered With Semaglutide in Adult Participants With Type 2 Diabetes (T2D) and Overweight or Obesity
Adults With Overweight/Obesity and Type 2 Diabetes
Phase 2
Interventional 150 participants sought
CenExel Savannah — Savannah, Georgia (6.1 mi)
· Sponsor: Antag Therapeutics
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Gynecologic Oncology and Surgical Specialists at the Lewis Cancer & Research Pavilion — Savannah, Georgia (6.1 mi)
· Sponsor: American Society of Clinical Oncology
SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
Hemophilia A With Inhibitor, Hemophilia B With Inhibitor
Phase 4
Interventional 55 participants sought
Willett Children's Hospital at Memorial University Medical Center — Savannah, Georgia (6.1 mi)
· Sponsor: American Thrombosis and Hemostasis Network
Efficacy of PP-01 in Mitigating Cannabis Withdrawal Symptoms in Adults With Cannabis Use Disorder
Cannabis Withdrawal
Phase 3
Interventional 420 participants sought
CenExel iResearch, LLC — Savannah, Georgia (6.1 mi)
· Sponsor: PleoPharma, Inc.
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor
Phase 2
Interventional 256 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi)
· Sponsor: Children's Oncology Group
A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization
Bronchiectasis With Pseudomonas Aeruginosa Colonization
Phase 2
Interventional 435 participants sought
Research Site — Rincon, Georgia (18.7 mi)
· Sponsor: AstraZeneca
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
Colorectal Cancer Stage II, Colorectal Cancer Stage III
Phase 3
Interventional 1,057 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2, Phase 3
Interventional 1,122 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
Atopic Dermatitis
Phase 3
Interventional 675 participants sought
Aeroallergy Research Laboratory /ID# 267247 — Savannah, Georgia (6.1 mi)
· Sponsor: AbbVie
Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease
Diabetic Kidney Disease (DKD)
Phase 2
Interventional 270 participants sought
Privia Medical Group of Georgia, LLC — Savannah, Georgia (6.1 mi)
· Sponsor: Regeneron Pharmaceuticals
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
Idiopathic Hypersomnia
Phase 3
Interventional 248 participants sought
Southeast Lung Associates Research — Rincon, Georgia (18.7 mi)
· Sponsor: Harmony Biosciences Management, Inc.
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
Generalized Anxiety Disorder (GAD)
Phase 2
Interventional 315 participants sought
iResearch Savannah /ID# 267865 — Savannah, Georgia (6.1 mi)
· Sponsor: AbbVie
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease, Overweight
Phase 3
Interventional 12,800 participants sought
Velocity Clinical Research - Savannah — Savannah, Georgia (6.1 mi)
· Sponsor: Amgen
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi)
· Sponsor: National Cancer Institute (NCI)
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
Phase 3
Interventional 1,670 participants sought
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler — Savannah, Georgia (6.1 mi)
· Sponsor: NRG Oncology
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
COVID-19 SARS-CoV-2 Infection
Phase 3
Interventional 2,330 participants sought
Velocity Clinical Research, Savannah — Savannah, Georgia (6.1 mi)
· Sponsor: Pfizer
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Cardiotoxicity, HER2/Neu Positive
Phase 3
Interventional 491 participants sought
Low Country Cancer Care — Savannah, Georgia (6.1 mi)
· Sponsor: SWOG Cancer Research Network
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
Agitation, Alzheimer Disease
Phase 2
Interventional 120 participants sought
CenExel iResearch, LLC — Savannah, Georgia (6.1 mi)
· Sponsor: Celgene